FY2025 EPS Estimate for TG Therapeutics Lifted by Analyst
TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) – Equities research analysts at Cantor Fitzgerald boosted their FY2025 earnings per share (EPS) estimates for shares of TG Therapeutics in a research report issued on Tuesday, March 4th. Cantor Fitzgerald analyst P. Agrawal now forecasts that the biopharmaceutical company will post earnings per share of $1.08 for […]
TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) – Equities research analysts at Cantor Fitzgerald boosted their FY2025 earnings per share (EPS) estimates for shares of TG Therapeutics in a research report issued on Tuesday, March 4th. Cantor Fitzgerald analyst P. Agrawal now forecasts that the biopharmaceutical company will post earnings per share of $1.08 for […]
